a public good project by the
Synthesis
Company
of California

© 2026

Katherine D. Crew | doi.page

0 works0 citations0 h-index

Katherine D. Crew

Columbia University Irving Medical Center(US)Columbia University(US)

Publications by Year

Research Areas

BRCA gene mutations in cancer, Cancer Genomics and Diagnostics, Global Cancer Incidence and Screening, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology

Most-Cited Works

→ Epidemiology of gastric cancer(2006)2,106 cited
→ Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast Cancer(2007)476 cited
→ Epidemiology of upper gastrointestinal malignancies(2004)327 cited
→ Randomized, Blinded, Sham-Controlled Trial of Acupuncture for the Management of Aromatase Inhibitor–Associated Joint Symptoms in Women With Early-Stage Breast Cancer(2010)280 cited
→ Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer(2018)279 cited
→ Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy(2010)268 cited

→ Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy(2013)

212 cited

→ Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial(2023)173 cited

→ High Prevalence of Vitamin D Deficiency Despite Supplementation in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy(2009)150 cited

→ Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer(2008)144 cited